Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.480
-0.130 (-8.07%)
At close: Mar 6, 2026, 4:00 PM EST
1.490
+0.010 (0.68%)
After-hours: Mar 6, 2026, 7:06 PM EST
Metagenomi Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$9.25
Upside
+525.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +372.97% | Aug 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +643.24% | Aug 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +710.81% | Aug 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +710.81% | May 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $16 | Buy | Maintains | $20 → $16 | +981.08% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $7 | Strong Buy | Maintains | $14 → $7 | +372.97% | Apr 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +1,251.35% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $14 | Strong Buy | Maintains | $7 → $14 | +845.95% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +372.97% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +913.51% | Nov 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +372.97% | Oct 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +372.97% | Sep 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +913.51% | Sep 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +372.97% | Aug 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +913.51% | Aug 19, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $22 → $17 | Buy | Maintains | $22 → $17 | +1,048.65% | Aug 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.